# Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST)

> **NCT01323400** · PHASE2 · COMPLETED · sponsor: **Centre Leon Berard** · enrollment: 81 (actual)

## Conditions studied

- GIST

## Interventions

- **DRUG:** Pazopanib
- **OTHER:** Best supportive care

## Key facts

- **NCT ID:** NCT01323400
- **Lead sponsor:** Centre Leon Berard
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2014-04
- **Final completion:** 2016-02
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2016-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01323400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01323400, "Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01323400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*